HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 105/4/1359    most recent 90629.2008v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via ISI Web of Science (1) Google Scholar Articles by Donato, A. J. Articles by Seals, D. R. PubMed PubMed Citation Articles by Donato, A. J. Articles by Seals, D. R.

HIGHLIGHTED TOPIC
Physiology of the Aging Vasculature

Cytochrome P-450 2C9 signaling does not contribute to age-associated vascular endothelial dysfunction in humans

Department of Integrative Physiology, University of Colorado, Boulder, Colorado

Submitted 9 May 2008 ; accepted in final form 28 July 2008

Oxidative stress impairs endothelium-dependent dilation (EDD) with aging in healthy sedentary adults. Increased cytochrome P-450 2C9 (CYP 2C9) signaling can contribute to oxidative stress-mediated suppression of EDD, but its role in aging is unknown. We hypothesized that inhibition of CYP 2C9 signaling with sulfaphenazole would improve EDD in older, but not young, healthy sedentary adults. At baseline, increases in forearm blood flow (FBF; venous occlusion plethysmography) in response to brachial artery infusions of ACh (1, 2, 4, and 8 µg·100 ml forearm volume^–1·min^–1), an endothelium-dependent dilator, were smaller in older [n = 14, 63 ± 1 (SE) yr] than in young (n = 11, 23 ± 2 yr) adults (P < 0.05), with a reduction in peak FBF of 32% (11.8 ± 1.7 vs. 17.3 ± 2.3 ml·100 ml tissue^–1·min^–1). Infusion of sulfaphenazole at doses that block CYP 2C9 signaling in humans did not affect the FBF responses to ACh in the older (peak FBF = 13.0 ± 4.3 ml·100 ml tissue^–1·min^–1, P = 0.41) or the young (peak FBF = 17.1 ± 1.9 ml·100 ml tissue^–1·min^–1, P = 0.55) adults. Coadministration of the nitric oxide inhibitor L-NMMA and sulfaphenazole decreased the FBF response to ACh in young and older subjects (P < 0.05); the effect was smaller in the older subjects, but group differences in EDD remained (P < 0.05). Endothelium-independent dilation assessed with sodium nitroprusside was not different in the young and older subjects. These results provide the first support for the concept that increased CYP 2C9 signaling does not contribute to impairments in EDD with aging in healthy adults.

endothelium-dependent dilation; oxidative stress; arterial aging